Cipla

  • Make essential drugs affordable for all: Cipla 04-05-2014 02:32 PM

    New Delhi: Amid US firms' allegations of patent norm violations against Indian pharma companies, leading domestic drug maker Cipla has said that "essential" medicines be made available to people at affordable rates and should not be sold under "monopoly". "As a scientist I believe that an inventor or innovator of...
  • Sensex ends 67 points up to end at record close 05-03-2014 04:36 PM

    Mumbai: The benchmark Sensex on Wednesday extended gains by rising 67 points to end near its record close on sustained buying driven by positive global cues. Thawing of Ukraine crisis and upbeat economic data from China helped domestic markets, said traders. After gaining 263.08 points in the previous session, the...
  • Sensex surges nearly 257 points to end at 21,289.49 15-01-2014 09:26 AM

    Mumbai: All-round buying after wholesale inflation declined to a five-month low lifted the benchmark Sensex today by nearly 257 points to its highest level since December 9 on hopes the RBI will lower interest rate to boost economic growth. The NSE barometer Nifty also jumped over 79 points to reclaim...
  • Shape up, or we'll ship out: India Inc to policymakers 09-09-2013 02:08 PM

    After the rapid slide in the rupee this year, the message from the country's corporate titans to the government is clear: shape up and fix the problems or more companies will expand their business abroad and deprive the economy of investment. Many, such as entrepreneur Kiran Mazumdar-Shaw, are already doing...
  • Cipla appoints Subhanu Saxena as new CEO 22-11-2012 09:16 AM

    Bangalore: Drug-maker Cipla on Thursday said it has appointed Subhanu Saxena as the Chief Executive Officer of the company. The appointment is effective from February 1, 2013. Saxena has more than 25 years of work experience. He has worked with companies such as Citicorp, The Boston Consulting Group and PepsiCo,...
  • Cipla launches HIV/AIDS treatment kit at Rs 158 14-08-2012 05:37 PM

    New Delhi: Drug major Cipla on Tuesday said it has launched 'Qvir', a four-drug kit priced at Rs 158 per kit to be used for treating HIV/AIDS. The kit consists of two tablets packaged together in one strip which represents a single day's treatment, Cipla said in a statement. Commenting...
  • Drug safety norms being severely compromised 14-05-2012 06:16 AM

    Mumbai: A Parliamentary committee has uncovered a nexus between doctors, government bodies and pharmacy companies to approve new drugs without the mandatory clinical trials. The doctors from top hospitals wrote to the country's Drug Controller General, to allow new drugs to be marketed, without clinical trials - a shocking lapse,...
  • Cancer drugs to cost less, Cipla slashes prices 05-05-2012 07:51 AM

    Mumbai: After the Indian government recently lifted a patent license, Indian pharma major, Cipla, has announced a massive reduction of up to 76 per cent in its cancer drug prices. Following the move, the price of Cipla's generic kidney cancer drug, Sorafenib, will be available at Rs 6,840 a month...
  • It's Congress vs Congress in Goa SEZ battle 02-01-2008 11:13 PM

    Kolkata: South African skipper Graeme Smith says his team has encountered vastly varying pitches in the cricket World Cup and the experience was likely to stretch on as they take on Bangladesh in the last group league game in Dhaka on Saturday. However, he sees no problem in adapting to...
  • India 360: TN fumes over 'morning after pill' ad 22-08-2007 03:35 AM

    The TN govt has sent a notice to a magazine for publishing i-pill ads. ...
  • India's own once-a-day AIDS drug 13-10-2006 03:51 PM

    ...